期刊文献+

BCRP过表达对乳腺癌细胞增殖和凋亡的影响 被引量:4

Influence of BCRP overexpression on proliferation and apoptosis of human breast cancer cells
下载PDF
导出
摘要 目的探讨乳腺癌耐药蛋白(BCRP)基因过表达对人乳腺癌细胞MDA-MB-435S增殖和凋亡的影响。方法取对数生长期的MDA-MB-435S细胞,将其随机分为三组,阳性转染组将真核表达质粒pc DNA3.1/BCRP经双酶切和测序鉴定后转染MDA-MB-435S细胞,阴性对照组同步转染2μg pc DNA3.1的空质粒,空白对照组用2 m L原培养液正常培养。采用RT-PCR法和Western blotting法检测BCRP mRNA和蛋白表达。转染后48 h,每组再分设7个丝裂霉素(MMC)浓度(0.01、0.10、2.50、5.00、10.00、20.00、40.00μmol/L)组,每个浓度组3个复孔,加入相应浓度的MMC 10μL,采用CCK-8法检测细胞增殖情况;流式细胞术分析细胞凋亡情况。结果重组真核表达质粒pc DNA3.1/BCRP经双酶切和测序证实该质粒构建正确;阳性转染组转染24、48、72 h后,MDA-MB-435S细胞中BCRP mRNA和蛋白表达均明显增加(P均<0.05);与阴性对照组比较,阳性转染组转染pc DNA3.1/BCRP 48 h后,细胞凋亡率无统计学差异(P>0.05);CCK-8结果显示,化疗药物MMC作用24 h后,与阴性对照组比较,阳性转染组转染pc DNA3.1/BCRP 48h后细胞存活率显著增加(P<0.05)。结论 BCRP过表达可促进人乳腺癌细胞MDA-MB-435S增殖,但对细胞凋亡无明显影响。 Objective To investigate the effect of breast cancer resistance protein( BCRP) overexpression on cell proliferation and apoptosis of breast cancer cells MDA-MB-435 S. Methods MDA-MB-435 S cells in the logarithmic phase were randomly divided into three groups: the positive transfection group,in which the eukaryotic expression plasmid pc DNA3. 1/BCRP was identified by restriction analysis and sequencing and then was transfected into MDA-MB-435 S cells,the positive control group,in which the cells were transfected with 2 μg pc DNA3. 1 empty plasmid at the same time,and the blank control group,in which the cells were cultured with 2 m L nutrient solution. The mRNA and protein expression of BCRP was determined by RT-PCR and Western blotting,respectively. After 48-hour transfection,7 mitomycin( MMC)concentration groups( 0. 01,0. 10,2. 50,5. 00,10. 00,20. 00,40. 00 μmol/L) were set up in each group,each concentration group had 3 complex holes which were added with 10 μL MMC. Cell counting kit-8( CCK-8) and flow cytometry were used to determine the influence of BCRP on cell proliferation and apoptosis of MDA-MB-435 S cells,respectively. Results Restriction analysis and sequencing proved that recombinant plasmid pc DNA3. 1/BCRP was constructed correctly.Both the expression of BCRP mRNA and protein was up-regulated in MDA-MB-435 S cells after transfection 24,48 or 72 h in the positive transfection group( P〈0. 05). No significant difference was found between the positive transfection group and the negative control group( P〈0. 05). After MMC treatment of 24 hours,CCK-8 showed that the cell survival rate in the transfection group was significantly higher than that of the negative control group( P〈0. 05). Conclusion BCRP overexpression promotes the proliferation of MDA-MB-435 S cells,but has no significant effect on apoptosis.
出处 《山东医药》 CAS 北大核心 2016年第25期20-23,共4页 Shandong Medical Journal
基金 国家自然科学基金资助项目(81573462) 辽宁省高等学校优秀人才支持计划项目(LJQ2015118)
关键词 乳腺癌 乳腺癌耐药蛋白 细胞增殖 细胞凋亡 breast carcinoma breast cancer resistance protein cell proliferation apoptosis
  • 相关文献

参考文献13

  • 1Untch M,Konecny GE,Paepke S,et al.Current and future role of neoadjuvant therapy for breast cancer[J].Breast,2014,23(5):526-537.
  • 2Ross DD,Yang W,Abruzzo LV,et al.A typical mutidrug resistance breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines[J].J Natl Cancer Inst,1999,91(5):429-433.
  • 3Sugimoto Y,Tsukahara S,Ishikawa E,et al.Breast cancer resistance protein:molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics[J].Cancer Sci,2005,96(8):457-465.
  • 4Yamagata T,Morishita M,Kusuhara H,et al.Characterization of the inhibition of breast cancer resistance protein-mediated efflux of mitoxantrone by pharmaceutical excipients[J].Int J Pharm,2009,370(1-2):216-219.
  • 5Molina JR,Kaufmann SH,Reid JM,et al.Evaluation of lapatinib and topotecan combination therapy:tissue culture,murine xenograft,and phaseⅠclinical trial data[J].Clin Cancer Res,2008,14(23):7900-7908.
  • 6Brooks TA,O'Loughlin KL,Minderman H,et al.The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein,multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells[J].Invest New Drugs,2007,25(2):115-122.
  • 7Dai CL,Liang YJ,Wang YS,et al.Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2[J].Cancer Lett,2009,279(1):74-83.
  • 8Nakanishi T,Bailey-Dell KJ,Hassel BA,et al.Novel 5 untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues:implications for drug resistance,tissues-specific expression,and alternative promoter usage[J].Cancer Res,2006,66(10):5007-5011.
  • 9Yamazaki R,Nishiyama Y,Furuta T,et al.Novel acrylonitrile derivatives,YHO-13177 and YHO-13351,reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo[J].Mol Cancer Ther,2011,10(7):1252-1263.
  • 10Singh A,Wu H,Zhang P,et al.Expression of ABCG2(BCRP)is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype[J].Mol Cancer Ther,2010,9(8):2365-2376.

同被引文献43

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部